University of California San Francisco
Give to UCSFA common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
UCSF is helping to create the first large group of Asian American study participants to help improve Alzheimer’s disease care for the Asian community North America.
A large, collaborative study on multiple sclerosis (MS) severity found that a single gene variant is predictive of much faster neurodegeneration in MS patients.
As part of its miniseries on Black excellence in STEM, Carry the One Radio interviewed UCSF’s Akinyemi Oni-Orisan, PharmD, PhD. The assistant professor of clinical pharmacy shares how he’s improving cardiovascular care for everyone and how he inspires confidence in himself and his students. Find it on your favorite podcast forum.
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
A new treatment approach draws on research into the unique teenage brain.
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.